Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Income Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Income Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
INCOME :
Gross Sales ₹10,677 Cr₹910,563 Cr₹8,071 Cr₹647 Cr₹61,007 Cr
     Sales ₹10,607 Cr₹904,838 Cr₹8,067 Cr₹646 Cr₹60,924 Cr
     Job Work/ Contract Receipts ₹21 Cr₹3,421 Cr---
     Processing Charges / Service Income ₹49 Cr₹2,304 Cr₹3.46 Cr₹0.25 Cr₹16 Cr
     Revenue from property development -----
     Other Operational Income ----₹68 Cr
Less: Excise Duty -----
Net Sales ₹10,260 Cr₹874,943 Cr₹7,782 Cr₹621 Cr₹58,719 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹-54 Cr₹29,074 Cr₹-450 Cr₹-25 Cr₹-105 Cr
Raw Material Consumed ₹3,252 Cr₹262,290 Cr₹2,871 Cr₹203 Cr₹18,885 Cr
     Opening Raw Materials ₹414 Cr₹39,862 Cr₹284 Cr₹25 Cr₹1,605 Cr
     Purchases Raw Materials ₹1,837 Cr₹182,940 Cr₹2,173 Cr₹141 Cr₹13,699 Cr
     Closing Raw Materials ₹409 Cr₹41,436 Cr₹399 Cr₹28 Cr₹2,331 Cr
     Other Direct Purchases / Brought in cost ₹1,410 Cr₹80,924 Cr₹814 Cr₹65 Cr₹5,912 Cr
     Other raw material cost -----
Power & Fuel Cost ₹125 Cr₹10,896 Cr₹103 Cr₹8.25 Cr₹800 Cr
     Electricity & Power ₹125 Cr₹10,896 Cr₹103 Cr₹8.25 Cr₹800 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹2,261 Cr₹191,847 Cr₹1,621 Cr₹142 Cr₹13,355 Cr
     Salaries, Wages & Bonus ₹2,094 Cr₹178,801 Cr₹1,515 Cr₹133 Cr₹12,714 Cr
     Contributions to EPF & Pension Funds ₹100 Cr₹8,896 Cr₹74 Cr₹5.87 Cr₹429 Cr
     Workmen and Staff Welfare Expenses ₹19 Cr₹2,191 Cr₹15 Cr₹1.16 Cr₹89 Cr
     Other Employees Cost ₹47 Cr₹1,959 Cr₹17 Cr₹1.54 Cr₹123 Cr
Other Manufacturing Expenses ₹173 Cr₹15,057 Cr₹160 Cr₹14 Cr₹1,092 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges -----
     Repairs and Maintenance ₹43 Cr₹3,887 Cr₹37 Cr₹2.70 Cr₹250 Cr
     Packing Material Consumed -----
     Other Mfg Exp ₹130 Cr₹11,170 Cr₹124 Cr₹11 Cr₹842 Cr
General and Administration Expenses ₹939 Cr₹100,080 Cr₹656 Cr₹45 Cr₹4,390 Cr
     Rent , Rates & Taxes ₹89 Cr₹13,196 Cr₹84 Cr₹5.86 Cr₹609 Cr
     Insurance ₹18 Cr₹1,544 Cr₹14 Cr₹1.04 Cr₹84 Cr
     Printing and stationery ₹9.50 Cr₹1,042 Cr₹7.02 Cr₹0.53 Cr₹43 Cr
     Professional and legal fees ₹203 Cr₹16,935 Cr₹88 Cr₹4.94 Cr₹308 Cr
     Traveling and conveyance ₹378 Cr₹49,605 Cr₹358 Cr₹27 Cr₹2,695 Cr
     Other Administration ₹242 Cr₹17,758 Cr₹105 Cr₹5.77 Cr₹651 Cr
Selling and Distribution Expenses ₹924 Cr₹63,811 Cr₹708 Cr₹59 Cr₹4,267 Cr
     Advertisement & Sales Promotion ₹601 Cr₹37,367 Cr₹452 Cr₹39 Cr₹2,553 Cr
     Sales Commissions & Incentives ₹198 Cr₹18,049 Cr₹174 Cr₹14 Cr₹1,244 Cr
     Freight and Forwarding ₹125 Cr₹8,367 Cr₹82 Cr₹6.15 Cr₹470 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses ₹0.15 Cr₹28 Cr₹0.22 Cr₹0.02 Cr-
Miscellaneous Expenses ₹125 Cr₹11,696 Cr₹121 Cr₹11 Cr₹1,587 Cr
     Bad debts /advances written off ₹4.62 Cr₹464 Cr₹4.92 Cr₹0.06 Cr₹6.12 Cr
     Provision for doubtful debts ₹7.96 Cr₹915 Cr₹9.65 Cr₹0.11 Cr₹59 Cr
     Losson disposal of fixed assets(net) --₹3.74 Cr₹0.30 Cr-
     Losson foreign exchange fluctuations ----₹10 Cr
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹112 Cr₹10,317 Cr₹103 Cr₹10 Cr₹1,511 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹7,745 Cr₹684,750 Cr₹5,791 Cr₹457 Cr₹44,272 Cr
Operating Profit (Excl OI) ₹2,515 Cr₹190,193 Cr₹1,991 Cr₹165 Cr₹14,447 Cr
Other Income ₹280 Cr₹12,857 Cr₹196 Cr₹17 Cr₹1,038 Cr
     Interest Received ₹40 Cr₹1,276 Cr₹13 Cr₹3.83 Cr₹129 Cr
     Dividend Received -₹0.24 Cr₹0.00 Cr₹0.04 Cr₹43 Cr
     Profit on sale of Fixed Assets ₹0.48 Cr₹166 Cr--₹19 Cr
     Profits on sale of Investments ----₹351 Cr
     Provision Written Back ₹2.48 Cr₹415 Cr₹34 Cr₹0.77 Cr-
     Foreign Exchange Gains ₹8.44 Cr₹1,041 Cr₹8.85 Cr₹0.05 Cr-
     Others ₹229 Cr₹9,958 Cr₹140 Cr₹12 Cr₹496 Cr
Operating Profit ₹2,795 Cr₹203,050 Cr₹2,187 Cr₹182 Cr₹15,485 Cr
Interest ₹34 Cr₹4,576 Cr₹60 Cr₹2.12 Cr₹232 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan ₹19 Cr₹3,605 Cr₹16 Cr₹1.55 Cr₹137 Cr
     Intereston Fixed deposits -----
     Bank Charges etc ₹6.42 Cr₹130 Cr₹4.02 Cr₹0.19 Cr₹17 Cr
     Other Interest ₹8.71 Cr₹842 Cr₹40 Cr₹0.38 Cr₹78 Cr
PBDT ₹2,761 Cr₹198,473 Cr₹2,127 Cr₹180 Cr₹15,253 Cr
Depreciation ₹378 Cr₹32,592 Cr₹167 Cr₹12 Cr₹991 Cr
Profit Before Taxation & Exceptional Items ₹2,383 Cr₹165,881 Cr₹1,960 Cr₹168 Cr₹14,262 Cr
Exceptional Income / Expenses -----
Profit Before Tax ₹2,398 Cr₹167,124 Cr₹1,975 Cr₹169 Cr₹14,377 Cr
Provision for Tax ₹457 Cr₹36,156 Cr₹522 Cr₹40 Cr₹3,816 Cr
     Current Income Tax ₹495 Cr₹33,199 Cr₹451 Cr₹39 Cr₹4,084 Cr
     Deferred Tax ₹-31 Cr₹4,117 Cr₹49 Cr₹0.24 Cr₹-327 Cr
     Other taxes ₹-7.22 Cr₹-1,160 Cr₹21 Cr₹0.14 Cr₹59 Cr
Profit After Tax ₹1,941 Cr₹130,968 Cr₹1,453 Cr₹129 Cr₹10,561 Cr
Extra items ₹0.98 Cr----
Minority Interest ₹-29 Cr₹-2,782 Cr₹-19 Cr₹-2.76 Cr₹-257 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹1,913 Cr₹128,186 Cr₹1,433 Cr₹127 Cr₹10,304 Cr
Adjustments to PAT -----
Profit Balance B/F ₹8,012 Cr₹673,519 Cr₹5,304 Cr₹407 Cr₹34,076 Cr
Appropriations ₹9,925 Cr₹801,705 Cr₹6,737 Cr₹533 Cr₹44,380 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹6.27 Cr₹485 Cr₹1.80 Cr₹2.74 Cr₹2,484 Cr
Equity Dividend % ----₹310.00
Earnings Per Share ₹47.75₹32.00₹35.78₹31.59₹25.72
Adjusted EPS ₹47.75₹32.00₹35.78₹31.59₹25.72

Compare Income Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹105,746.1 Cr 0.8% 8.4% 26.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,864.0 Cr -4.3% -3% -0.7% Stock Analytics
DIVIS LABORATORIES ₹168,811.0 Cr -3.3% -7.4% 34.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹124,352.0 Cr 1.4% 10.1% 17.9% Stock Analytics
CIPLA ₹121,260.0 Cr -4.4% -0.5% 0.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,786.0 Cr -5.2% -5.7% -5.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.8%

8.4%

26.4%

SENSEX

-1.1%

-3.4%

-1.1%


You may also like the below Video Courses